Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.

Salomao M, Remotti H, Vaughan R, Siegel AB, Lefkowitch JH, Moreira RK.

Hum Pathol. 2012 May;43(5):737-46. doi: 10.1016/j.humpath.2011.07.005. Epub 2011 Oct 20.

PMID:
22018903
2.

Liver pathology in obesity.

Suriawinata A, Fiel MI.

Semin Liver Dis. 2004 Nov;24(4):363-70. Review.

PMID:
15605304
3.

Nonalcoholic steatohepatitis.

Brunt EM.

Semin Liver Dis. 2004 Feb;24(1):3-20. Review.

PMID:
15085483
4.

Natural history of nonalcoholic steatohepatitis.

Liou I, Kowdley KV.

J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S11-6. Review.

PMID:
16540761
5.

Obesity and hepatocellular carcinoma.

Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103. Review.

PMID:
15508109
6.

Primary liver cancers with nonalcoholic steatohepatitis.

Hashizume H, Sato K, Takagi H, Hirokawa T, Kojima A, Sohara N, Kakizaki S, Mochida Y, Shimura T, Sunose Y, Ohwada S, Mori M.

Eur J Gastroenterol Hepatol. 2007 Oct;19(10):827-34. Review.

PMID:
17873605
7.

Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.

Rahimi RS, Landaverde C.

Nutr Clin Pract. 2013 Feb;28(1):40-51. doi: 10.1177/0884533612470464. Epub 2013 Jan 3. Review.

PMID:
23286927
8.

Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma.

Duan XY, Qiao L, Fan JG.

Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):18-27. Review.

PMID:
22251466
9.

Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.

Lackner C.

Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):223-31. doi: 10.1586/egh.11.8. Review.

PMID:
21476917
10.

Genomic aspects of NAFLD pathogenesis.

Naik A, Košir R, Rozman D.

Genomics. 2013 Aug;102(2):84-95. doi: 10.1016/j.ygeno.2013.03.007. Epub 2013 Mar 29. Review.

11.

Review article: steatosis, the metabolic syndrome and cancer.

Bugianesi E.

Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:40-3. Review.

12.

[Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].

Jansen PL.

Ned Tijdschr Geneeskd. 2005 Feb 5;149(6):289-94. Review. Dutch.

PMID:
15730035
13.

Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Zafrani ES.

Virchows Arch. 2004 Jan;444(1):3-12. Epub 2003 Dec 18. Review.

PMID:
14685853
14.

Hepatocellular carcinoma with nonalcoholic steatohepatitis.

Mori S, Yamasaki T, Sakaida I, Takami T, Sakaguchi E, Kimura T, Kurokawa F, Maeyama S, Okita K.

J Gastroenterol. 2004;39(4):391-6. Review.

PMID:
15168253
15.

Pathology of nonalcoholic fatty liver disease.

Yeh MM, Brunt EM.

Am J Clin Pathol. 2007 Nov;128(5):837-47. Review.

PMID:
17951208
16.

Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.

Mills SJ, Harrison SA.

Curr Gastroenterol Rep. 2005 Feb;7(1):32-6. Review.

PMID:
15701296
17.

[Steatosis and steatohepatitis in diabetic patient].

Hůlek P, Dresslerová I.

Vnitr Lek. 2011 Apr;57(4):364-7. Review. Czech.

PMID:
21612059
18.

[Is non alcoholic steatohepatitis (NASH) part of the metabolic syndrome?].

Fehér J, Németh E, Lengyel G.

Orv Hetil. 2004 Jul 18;145(29):1499-506. Review. Hungarian.

PMID:
15453020
19.

Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.

Degasperi E, Colombo M.

Lancet Gastroenterol Hepatol. 2016 Oct;1(2):156-164. doi: 10.1016/S2468-1253(16)30018-8. Epub 2016 Sep 8. Review.

PMID:
28404072

Supplemental Content

Support Center